Change control or change management is an integral part of todays regulated pharmaceutical and medical device industries (as well as others). The need to control and assess changes being made to previously approved documents ensures that any and all changes are implemented in a careful and thoughtful way.
An all too common observation during a regulatory audit or during a product nonconformance investigation is that changes were made to the product through the product documentation that were actually harmful to the product performance or that proper studies were not undertaken to ensure the product continued to meet design goals. Another consequence of an inadequate change control strategy is when making changes to one product adversely impacts another product or multiple products.
When assessing changes, it is important to take risk management into consideration before, during and after the change. Determining the risk level of the change can guide how or even if the change is implemented.
Course Objectives:
• Understand the change control process.
• Understand the critically important impact assessment process and develop tools for effective impact assessments.
• Learn how to integrate risk management into the change control process.
Course Outline:
I. Impact assessment as a part of change control
a. The ability to assess the impact of a change is integral to the process of change control
b. Must be an integral part of your change control procedure
c. Not an option
II. Why do an impact assessment as part of change control?
a. Regulatory guidance talks to ensuring all changes are reviewed, verified and/or validated as appropriate
b. Determination of “appropriate” is a little vague.
c. Regulatory guidance does not provide much guidance on how to do an impact assessment
d. The process and procedure must be part of internal SOPs
III. Quick review of the elements of a change description
a. The change
b. The reason
c. The justification
i. The justification comes from the impact assessment
ii. You can’t justify the change without assessing the impact of the change first
IV. Low impact changes
a. Not all changes require a comprehensive impact assessment
b. There should be a predefined list of changes or change types that do not require a full impact assessment to justify
c. This list of changes or change types should be part of an SOP and fairly short and well defined
V. Impact assessment team
a. If it is determined that a full impact assessment is needed a team to do the assessment should be put together
b. Can be permanent group or put together as needed
c. Need someone to drive the change
i. Acts as the project manager for the change
d. Other functional areas depending on the nature of the change
VI. Creating a change control roadmap
a. The use of forms and decision trees is essential to success
b. Team needs to have guidance and a place to record impact decisions
c. Examples of decision tree and change impact assessment form
d. Understanding of risk management impact
i. Simple tool for risk management during change control
e. Understanding regulatory impact
VII. Conclusions and questions
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
This webinar is for professionals in the Pharmaceutical, Medical Device, or Combination Product industries with responsibilities in the following areas:
• Quality Systems
• Quality Assurance
• Quality Control
• Change Control
• Engineering/R&D
• Regulatory Affairs
• Validation
• Auditors
• GMP trainers
• Consultants
Implementing a Modern Quality Risk Management
Get Instant Access 60 Minutes View Program |
Compliant Management Controls under 21 CFR 820 and ISO 13485
Get Instant Access 60 Minutes View Program |
Effective Records Management & Document Control for Medical Devices
Get Instant Access 60 Minutes View Program |
The Use and Misuse Of FMEA In Medical Device Risk Management
Get Instant Access 75 Minutes View Program |
Project Management for Computer Systems Validation and 21 CFR 11 / Annex 11
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry